Compare KOP & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KOP | IART |
|---|---|---|
| Founded | 1988 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Forest Products | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 689.3M | 731.1M |
| IPO Year | 2005 | 1996 |
| Metric | KOP | IART |
|---|---|---|
| Price | $38.24 | $9.12 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 7 |
| Target Price | ★ $52.50 | $14.50 |
| AVG Volume (30 Days) | 238.1K | ★ 761.3K |
| Earning Date | 05-08-2026 | 05-04-2026 |
| Dividend Yield | ★ 0.95% | N/A |
| EPS Growth | ★ 11.38 | N/A |
| EPS | ★ 2.74 | N/A |
| Revenue | ★ $1,879,300,000.00 | N/A |
| Revenue This Year | $3.23 | $4.45 |
| Revenue Next Year | $2.32 | $3.40 |
| P/E Ratio | $13.84 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $23.54 | $8.70 |
| 52 Week High | $39.50 | $21.95 |
| Indicator | KOP | IART |
|---|---|---|
| Relative Strength Index (RSI) | 58.86 | 35.56 |
| Support Level | $26.62 | $8.70 |
| Resistance Level | $39.39 | $14.14 |
| Average True Range (ATR) | 1.23 | 0.43 |
| MACD | -0.13 | 0.07 |
| Stochastic Oscillator | 72.61 | 35.57 |
Koppers Holdings Inc through its subsidiaries, manufactures and sells wood products, wood treatment chemicals, and carbon compounds used in markets such as railroad, aluminum and steel, agriculture, utilities, and residential lumber. The company is organized into three business segments: railroad and utility products and services, performance chemicals, and carbon materials and chemicals. Its product portfolio includes treated and untreated wood products like crossties used in railroads, wood preservation chemicals, and carbon compounds such as creosote used in the treatment of wood crossties, among others. The majority of its revenue comes from the company's railroad and utility products and services segment, and more than half of the company's revenue is earned in the United States.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.